Clinical Trial Update: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating S-337395 for respiratory syncytial virus in symptomatic nonhospitalized adults at high risk of progression to severe disease; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• S-337395

Snippet

Sponsor: Shionogi | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: RECRUITING